Beta-caryophyllene restores blood pressure, heart rate, and electrocardiographic alterations while mitigating cardiometabolic biomarkers in a rat model of metabolic syndrome: Implications for non-communicable disease prevention.
Background: Metabolic Syndrome (MS) is an escalating non-communicable disease (NCD) and public health crisis heavily driven by modern high-calorie dietary transitions. MS is closely linked to catastrophic cardiovascular dysfunction (CVD). Conventional CVD medications are frequently constrained by high financial costs, system-wide adverse effects, and poor population-level accessibility in…
We haven't written up this one. bioRxiv has the full story — the link below goes straight to it.
